By analyzing genomic, transcriptomic, proteomic, and tissue microarray data across multiple independent patient cohorts, the study found that NSD3 amplification is consistently associated with a non-inflamed, immune-cold tumor microenvironment, marked by low immune infiltration and poor expression of immune activation genes. Here, NSD3 is linked to neoplasm.